IL2 and cancer: According to the results of GSEA in pan-cancer, NCBP2 was closely related to immune related pathways, such as IFN-alpha response, IFN-gamma response, IL-6/JAK/STAT3 signaling, IL-2/STAT5 signaling, allograft-rejection pathways, inflammatory response, and TNF alpha signaling-via NFKB.